No Data
Zhejiang Shouxiangu Pharmaceutical (603896.SH): has developed a series of vitamin health food products in reserve.
On August 9, Gelunhui reported that Zhejiang Shouxiangu Pharmaceutical (603896.SH) stated on the investor interaction platform that in order to adapt to changes in market demand, the company has developed a series of vitamin-based health foods and obtained health food filing certificates to meet the health needs of different channels and different groups of people. Currently, the company has not yet formed a scale sales of vitamin-based products. Please pay attention to investment risks.
Zhejiang Shouxiangu Pharmaceutical (603896.SH): won the first prize of the National Science and Technology Progress Award.
On June 24, 2024, the National Science and Technology Awards Conference for 2023 was held in Beijing. The "Key Technology Innovation and Application of Food and Medicinal Fungi Full Industry Chain" project submitted by Jilin Agricultural University as the leader, Professor Li Yu of the Chinese Academy of Engineering as the head, Zhejiang Shouxiangu Pharmaceutical Co., Ltd. as the co-completion unit, and Dr. Li Zhenhao, Vice Chairman of Shouxiangu, as the co-completion person, won the National Science and Technology Progress Award first prize. This is the company's third award following the first prize of Zhejiang Provincial Science and Technology Progress Award and the Science and Technology Award of the China Light Industry Federation in 2023.
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.'s (SHSE:603896) Business And Shares Still Trailing The Market
Zhejiang Shouxiangu Pharmaceutical (603896.SH) plans to distribute a dividend of 0.39 yuan per share in 2023, with the ex-rights and ex-dividend date on June 20th.
Zhejiang Shouxiangu Pharmaceutical (603896.SH) announced that the equity distribution plan for the company in 2023 is to distribute RMB [unknown number] to all shareholders.
Shou Xian Valley (603896.SH): No cooperation with Zhejiang Hospital of Traditional Chinese Medicine on Wu Mei Soup
Gelonghui, May 27丨Shouxiangu (603896.SH) said on the investor interactive platform that the company has yet to cooperate with Zhejiang Hospital of Traditional Chinese Medicine on Wumei Soup.
Shouxianggu (603896.SH): Did not participate in this Shenzhou 17 space flight test
Gelonghui, May 7, 丨 Shouxiangu (603896.SH) said on the investor interactive platform that the company carried out six space breeding work in 2003, 2005, 2012, 2013, 2016 and 2021, respectively, and did not participate in this Shenzhou 17 space launch test.
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.'s (SHSE:603896) Prospects Need A Boost To Lift SharesNo Data
